Jelena Aleksic

Jelena Aleksic is the Founder and CBO at PharmEnable Therapeutics, a drug discovery company utilizing AI to develop innovative drugs. Jelena also works as a Business Mentor at P4 Precision Medicine Accelerator and Accelerate@Babraham, and serves as a Trustee at TReND in Africa. Previously, Jelena was the Director at SparkBio Ltd and held various leadership roles at Raremark, GeneAdviser, and the Cambridge Rare Disease Network. Jelena has a PhD in Genome Sciences/Genomics from the University of Cambridge and a Bachelor of Science in Genetics from The University of Edinburgh. In their previous role, Jelena worked as a post-doctoral research associate at the University of Cambridge, focusing on stem cell biology.